Compare WhiteOak Capital Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.36
1.93
NAV
₹13.82
₹428.69
Fund Started
16 Jan 2024
04 Jun 1999
Fund Size
₹491.85 Cr
₹3822.73 Cr
Exit Load
Exit load of 1%, if redeemed within 1 months.
Exit load of 0.50% if redeemed within 15 days
1 Year
13.37%
7.42%
3 Year
-
25.82%
5 Year
-
17.14%
Equity
98.66%
98.53%
Cash
-0.83%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.72% |
JB Chemicals & Pharmaceuticals Ltd. | 9.11% |
Divi's Laboratories Ltd. | 5.48% |
Fortis Healthcare Ltd. | 5.33% |
Lupin Ltd. | 5.16% |
Apollo Hospitals Enterprise Ltd. | 4.90% |
Max Healthcare Institute Ltd. | 4.52% |
Laurus Labs Ltd. | 4.41% |
Alkem Laboratories Ltd. | 3.36% |
Krishna Institute of Medical Sciences Ltd | 2.71% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
16 Jan 2024
04 Jun 1999
